Insilico Biotechnology AG

Meitnerstraße 8
70563 Stuttgart, Germany

Phone: +49 (0)711 460 594-0
Fax: +49 (0)711 460 594-10

Insilico Biotechnology is a market-leader in providing solutions and software for the simulation of living cells. The company has three main areas of operation: Biotechnological Process Optimisation, Pharmaceutical Testing, Software Engineering. Its interdisciplinary team of experts develops customised solutions for the efficient manufacturing of biotechnological products as well as for the stratified preclinical testing of drugs by combining high-performance computing with Insilico's proprietary software. For many global-leading companies from the chemical and pharmaceutical industries, Insilico's technology already lowers the time, costs and risks involved in their development processes.

Latest News of our Members

  • Insilico and Teva enter collaboration to apply predictive Digital Twins for biopharmaceutical production

    Insilico Biotechnology AG21.02.2019More
  • Gold für Symrise: Nachhaltigkeitsmanagement ausgezeichnet

    Symrise AG 4.02.2019More
  • Bayer Partners with Genedata to Digitalize Crop Science Research and Development

    Genedata GmbH27.09.2018More
  • All links

Membership Application

Do you want to become a member of the IWBio?

Download the membership application form here. (PDF in German version)

You can find our statute here. (PDF in German version)

In cases of questions or suggestions, please contact us here: +49 (0)30-374415-850